Table 3A.
Socio-demographic, diagnoses and T1-Since T2 treatments of the participants.
| Cognitive Remediation | At T1 (Before CR) | T1-Since T2 (After RC) | p value* |
|---|---|---|---|
| n or mean (% or SD) | n or mean (% or SD) | ||
| Socio-Demographics | |||
| Male Sex | 41 (62.1) | ||
| Age | 38,7 (93.9) | ||
| Years of study | 13,4 (2.9) | ||
| Diagnostics | |||
| Schizophrenia | 53 (80.3) | ||
| Bipolar | 3 (4.5) | ||
| Neurodevelopmental Disorder | 10 (15.2) | ||
| Any Treatment | |||
| Antipsychotics | 62 (93.9) | 63 (95.5) | 0.317 |
| Clozapin | 23 (34.8) | 25 (37.8) | 0.564 |
| Depot antipsychotics | 8 (12.1) | 9 (13.6) | 0.564 |
| Depot 1 injection/15 days | 8 (12.1) | 0 (0.0) | <0.001 |
| Equivalent chlorpromazine | 210,2 (184.8) | 226,5 (197.4) | 0.421 |
| Antidepressants | 30 (45.5) | 26 (39.4) | 0.317 |
| Mood stabilizers | 13 (19.7) | 13 (19.7) | 1.00 |
| Benzodiazepins | 7 (10.6) | 10 (15.2) | 0.366 |
| Anxiolytics or hypnotics | 12 (18.2) | 3 (4.5) | 0.020 |
| Methylphenidate | 2 (3.0) | 3 (4.5) | 0.317 |
*McNemar Chi-square Test or paired sample t test.